This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Policy and Terms of Use.
I accept
Publications
Publications
"Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions"
2022, Int. J. Mol. Sci., 23(8), 4401
"SANTAVAC™: A novel universal antigen composition for developing cancer vaccines"
2017, Recent Patents on Biotechnology, 11 (1): 32–41
"Allogeneic antigen composition for preparing universal cancer vaccines"
2016, Journal of Immunology Research, Article ID 5031529, PMID: 27781211
"Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC)"
2015, Human Vaccines & Immunotherapeutics, 11 (3): 689-698
"Universal cancer vaccine: an update on the design of cancer vaccines generated from endothelial cells"
2013, Human Vaccines & Immunotherapeutics, 9 (7): 1549-1552
"Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro"
2013, Human Vaccines & Immunotherapeutics, 9 (1): 198-209
"Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrence"
2012, Molecular & cellular proteomics, 11 (2): M111.014480
"Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens"
2010, Journal of Cancer, 1: 230-241
"Proteolytically-cleaved fragments of cell surface proteins stimulate a cytotoxic immune response against tumor-activated endothelial cells in vitro"
2010, Journal of Cancer Science & Therapy, 2: 126–131
"Proteolytically-cleaved fragments of cell-surface proteins from live tumor cells stimulate anti-tumor immune response in vitro"
2010, Journal of Carcinogenesis & Mutagenesis, 1: 1–3
"Cell proteomic footprint"
2009, Rapid Communications in Mass Spectrometry, 23: 680–682